To assess the relevance of GLI/STAT-mediated IDO1 expression and immunosuppression to human pathology, we analyzed different available bulk- ([10, 21, 45]) and single cell (for references see Additional file 1 supplementary information) RNA-seq data sets of melanoma and non-melanoma skin cancer patients. This evidence concerns the gene IDO1 and skin neoplasm.